Clinical Trials Browser

INDUSTRY × Advanced NSCLC × camrelizumab × Clear all

NCT05106335 2023-08-16

A Study to Evaluate Camrelizumab Combined With Famitinib as Subsequent Therapy in Patients With Advanced NSCLC

Phase 3 Terminated

Advanced NSCLC